Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Weinblatt, 1994, Methotrexate in rheumatoid arthritis: a five year prospective study., Arthritis Rheum, 37, 1492, 10.1002/art.1780371013

Maetzel, 1998, How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey., J Rheumatol, 25, 2331

Tugwell, 1995, Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis., N Engl J Med, 333, 137, 10.1056/NEJM199507203330301

O'Dell, 1996, Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination-of all three medications., N Engl J Med, 334, 1287, 10.1056/NEJM199605163342002

Wolfe, 1990, Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts., J Rheumatol, 17, 994

Maini, 1995, Monoclonal anti-TNFα antibody as a probe of pathogenesis and therapy of rheumatoid disease., Immunol Rev, 144, 195, 10.1111/j.1600-065X.1995.tb00070.x

Feldmann, 1996, Role of cytokines in rheumatoid arthritis., Ann Rev Immunol, 14, 397, 10.1146/annurev.immunol.14.1.397

Knight, 1993, Construction and initial characterisation of a mouse-human chimaeric anti-TNF antibody., Mol Immunol, 30, 1443, 10.1016/0161-5890(93)90106-L

Elliott, 1993, Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α., Arthritis Rheum, 36, 1681, 10.1002/art.1780361206

Elliott, 1994, Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis., Lancet, 344, 1105, 10.1016/S0140-6736(94)90628-9

Elliott, 1994, Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis., Lancet, 344, 1125, 10.1016/S0140-6736(94)90632-7

Rankin, 1995, The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis., Br J Rheum, 34, 334, 10.1093/rheumatology/34.4.334

Moreland, 1997, Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein., N Engl J Med, 337, 141, 10.1056/NEJM199707173370301

Moreland, 1999, Etanercept therapy in rheumatoid arthritis: a randomized controlled trial., Ann Intern Med, 130, 478, 10.7326/0003-4819-130-6-199903160-00004

Maini, 1998, Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis., Arthritis Rheum, 41, 1552, 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W

Weinblatt, 1999, A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate., N Engl J Med, 340, 253, 10.1056/NEJM199901283400401

Hochberg, 1992, The American College of Rheumatology 1991 revised criteria for the classification of global function status in rheumatoid arthritis., Arthritis Rheum, 35, 498, 10.1002/art.1780350502

Felson, 1995, American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis., Arthritis Rheum, 38, 727, 10.1002/art.1780380602

Fries, 1982, The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales., J Rheumatol, 9, 789

Surveillance, Epidemiology and End Results [SEER] Program Public Use CD-ROM (1973–1995), National Cancer Institute, DCPC, Surveillance Program, Cancer Statistics Branch, released April 1998, based on August 1997 submission.

Williams, 1996, Lymphoma and leukemia in rheumatoid arthritis: are they associated with azathioprine, cyclophosphamide, or methotrexate?, J Clin Rheum, 2, 64, 10.1097/00124743-199604000-00002

Jones, 1996, Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study., Br J Rheum, 35, 738, 10.1093/rheumatology/35.8.738

Baecklund, 1998, Disease activity and risk of lymphoma in patients with rheumatoid arthritis: a nested case-control study., BMJ, 317, 180, 10.1136/bmj.317.7152.180